vs
SuperCom Ltd（SPCB）与SUTRO BIOPHARMA, INC.（STRO）财务数据对比。点击上方公司名可切换其他公司
SuperCom Ltd的季度营收约是SUTRO BIOPHARMA, INC.的1.2倍（$14.2M vs $11.6M），SuperCom Ltd同比增速更快（-1.5% vs -21.4%）
Super.com是一家总部位于美国旧金山的科技公司，由侯赛因·法扎勒和施亨利联合创立。该公司主营金融服务业务，具体涵盖会员奖励计划以及旅行预订等相关服务，在出行与消费金融领域深耕发展。
Sutro Biopharma是一家上市生物科技公司，总部位于加州南旧金山，专注于临床阶段药物的研发、开发与生产。公司依托自主专有的无细胞蛋白质合成平台，结合蛋白质工程与理性设计技术开发肿瘤治疗药物。公司2003年成立时名为Fundamental Applied Biology，2009年改用现名。
SPCB vs STRO — 直观对比
营收规模更大
SPCB
是对方的1.2倍
$11.6M
营收增速更快
SPCB
高出19.9%
-21.4%
损益表 — Q2 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.2M | $11.6M |
| 净利润 | $5.3M | — |
| 毛利率 | 61.2% | — |
| 营业利润率 | 16.3% | — |
| 净利率 | 37.5% | — |
| 营收同比 | -1.5% | -21.4% |
| 净利润同比 | 79.5% | 35.4% |
| 每股收益（稀释后） | $1.32 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收SPCBSTRO
| Q4 25 | — | $11.6M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | $14.2M | $63.7M | ||
| Q1 25 | — | $17.4M | ||
| Q4 24 | — | $14.8M | ||
| Q3 24 | — | $8.5M | ||
| Q2 24 | $14.4M | $25.7M | ||
| Q1 24 | — | $13.0M |
净利润SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | $-56.9M | ||
| Q2 25 | $5.3M | $-11.5M | ||
| Q1 25 | — | $-76.0M | ||
| Q4 24 | — | $-72.4M | ||
| Q3 24 | — | $-48.8M | ||
| Q2 24 | $3.0M | $-48.0M | ||
| Q1 24 | — | $-58.2M |
毛利率SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 61.2% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 52.3% | — | ||
| Q1 24 | — | — |
营业利润率SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | -499.9% | ||
| Q2 25 | 16.3% | -5.2% | ||
| Q1 25 | — | -393.8% | ||
| Q4 24 | — | -440.7% | ||
| Q3 24 | — | -797.2% | ||
| Q2 24 | 7.7% | -189.4% | ||
| Q1 24 | — | -435.0% |
净利率SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | -586.6% | ||
| Q2 25 | 37.5% | -18.0% | ||
| Q1 25 | — | -436.6% | ||
| Q4 24 | — | -489.2% | ||
| Q3 24 | — | -572.6% | ||
| Q2 24 | 20.6% | -186.8% | ||
| Q1 24 | — | -447.5% |
每股收益（稀释后）SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | $-0.67 | ||
| Q2 25 | $1.32 | $-0.14 | ||
| Q1 25 | — | $-0.91 | ||
| Q4 24 | — | $-27.63 | ||
| Q3 24 | — | $-0.59 | ||
| Q2 24 | $1.19 | $-0.59 | ||
| Q1 24 | — | $-0.59 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.0M | $141.4M |
| 总债务越低越好 | $23.6M | — |
| 股东权益账面价值 | $37.3M | $-132.5M |
| 总资产 | $65.5M | $173.8M |
| 负债/权益比越低杠杆越低 | 0.63× | — |
8季度趋势，按日历期对齐
现金及短期投资SPCBSTRO
| Q4 25 | — | $141.4M | ||
| Q3 25 | — | $167.6M | ||
| Q2 25 | $15.0M | $205.1M | ||
| Q1 25 | — | $249.0M | ||
| Q4 24 | — | $316.9M | ||
| Q3 24 | — | $388.3M | ||
| Q2 24 | $5.7M | $375.6M | ||
| Q1 24 | — | $267.6M |
总债务SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $23.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $29.2M | — | ||
| Q1 24 | — | — |
股东权益SPCBSTRO
| Q4 25 | — | $-132.5M | ||
| Q3 25 | — | $-87.3M | ||
| Q2 25 | $37.3M | $-32.1M | ||
| Q1 25 | — | $-25.8M | ||
| Q4 24 | — | $44.6M | ||
| Q3 24 | — | $111.2M | ||
| Q2 24 | $13.8M | $152.2M | ||
| Q1 24 | — | $98.0M |
总资产SPCBSTRO
| Q4 25 | — | $173.8M | ||
| Q3 25 | — | $209.7M | ||
| Q2 25 | $65.5M | $262.4M | ||
| Q1 25 | — | $321.4M | ||
| Q4 24 | — | $387.2M | ||
| Q3 24 | — | $451.8M | ||
| Q2 24 | $49.6M | $489.0M | ||
| Q1 24 | — | $403.4M |
负债/权益比SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.63× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.11× | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.2M | $-177.2M |
| 自由现金流经营现金流 - 资本支出 | $-3.6M | — |
| 自由现金流率自由现金流/营收 | -25.3% | — |
| 资本支出强度资本支出/营收 | 10.0% | — |
| 现金转化率经营现金流/净利润 | -0.41× | — |
| 过去12个月自由现金流最近4个季度 | $-14.0M | — |
8季度趋势，按日历期对齐
经营现金流SPCBSTRO
| Q4 25 | — | $-177.2M | ||
| Q3 25 | — | $-38.2M | ||
| Q2 25 | $-2.2M | $-44.7M | ||
| Q1 25 | — | $-67.9M | ||
| Q4 24 | — | $-71.7M | ||
| Q3 24 | — | $-64.5M | ||
| Q2 24 | $-950.0K | $9.5M | ||
| Q1 24 | — | $-64.7M |
自由现金流SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $-3.6M | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $-1.6M | — | ||
| Q1 24 | — | — |
自由现金流率SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -25.3% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -10.8% | — | ||
| Q1 24 | — | — |
资本支出强度SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.0% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 4.2% | — | ||
| Q1 24 | — | — |
现金转化率SPCBSTRO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | -0.41× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | -0.32× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
